IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ipca Laboratories Ltd. (IPCA)
Ipca Laboratories Ltd. stock price live, this page displays NSE IPCA stock exchange data. View the IPCA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ipca Laboratories Ltd. real time stock price chart below.
What Is the Ipca Laboratories Ltd. Stock Price Today?
The Ipca Laboratories Ltd. stock price today is 1,882.10.
What Is the Stock Symbol for Ipca Laboratories Ltd.?
The stock symbol for Ipca Laboratories Ltd. is "IPCA."
What Stock Exchange Does Ipca Laboratories Ltd. Trade On?
Ipca Laboratories Ltd. is listed and trades on the NSE stock exchange.
Is Ipca Laboratories Ltd. a Good Stock to Buy?
Determining whether Ipca Laboratories Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPCA quote. (ISIN: INE571A01038)
What Is the Ipca Laboratories Ltd. Stock Price Today?
The Ipca Laboratories Ltd. stock price today is 1,882.10.
What Is the Stock Symbol for Ipca Laboratories Ltd.?
The stock symbol for Ipca Laboratories Ltd. is "IPCA."
What Stock Exchange Does Ipca Laboratories Ltd. Trade On?
Ipca Laboratories Ltd. is listed and trades on the NSE stock exchange.
Is Ipca Laboratories Ltd. a Good Stock to Buy?
Determining whether Ipca Laboratories Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPCA quote. (ISIN: INE571A01038)
1,882.10
-2.50(-0.13%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,862.30
1,919.00
52 wk Range
1,251.60
1,945.10
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,862.301,919.00
52 wk Range
1,251.601,945.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IPCA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1,928.67
Upside
+2.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
IPCA Laboratories receives Investment Bank Analyst Rating Update- Investing.com
Pro
IPCA Laboratories receives Investment Bank Analyst Rating Update- Investing.com
Pro
- IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
IPCA Laboratories receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
15 Buy
2 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,928.67
(+2.47% Upside)
Ipca Laboratories Ltd. Earnings Call Summary for Q1/2027
- Ipca Labs Q1 FY27 EPS of 15.84 beat estimates by 27.4%; revenue rose 21% YoY to 27.88B rupees, exceeding forecasts by 7.7%.
- Consolidated EBITDA margin expanded 449 bps to 22.88% from 18.39%, driven by improved product mix and operating leverage.
- Company raised FY27 revenue growth guidance to 14%-16% from 12%-13%; lifted EBITDA margin outlook to 23% from 22%.
- Export sales surged 34% led by 70% growth in EU; U.S. business up 8% with 15%-17% growth expected for full year.
- Management eliminated working capital debt, plans 700-800 crore capex in FY27; biosimilar revenue expected only in FY29-30.
Last Updated: 2026-08-14, 07:22 a/m
Read Full TranscriptEarnings
Latest Release
Aug 13, 2026
EPS / Forecast
15.84 / 12.43
Revenue / Forecast
27.88B / 25.89B
Compare IPCA to Peers and Sector
Metrics to compare | IPCA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPCAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.5x | 30.2x | −0.3x | |
PEG Ratio | 0.53 | 0.32 | 0.00 | |
Price/Book | 5.9x | 4.6x | 2.6x | |
Price / LTM Sales | 4.7x | 4.1x | 3.1x | |
Upside (Analyst Target) | 6.5% | 9.7% | 50.4% | |
Fair Value Upside | Unlock | 5.5% | 6.4% | Unlock |
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetes, diabetology, emollients/protectives, fever, gastroenterology, haematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, regenerative, respiratory, rheumatology, and urology. The company also exports its products to Europe, Africa, the Americas, rest of Asia, the Commonwealth of Independent States, and Australasia. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ipca Laboratories (IPCA) Stock Price Today?
The Ipca Laboratories stock price today is 1,882.10 INR.
What Stock Exchange Does Ipca Laboratories Trade On?
Ipca Laboratories is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Ipca Laboratories?
The stock symbol for Ipca Laboratories is "IPCA."
Does Ipca Laboratories Pay Dividends? What’s The Current Dividend Yield?
The Ipca Laboratories dividend yield is 0.32%.
What Is the Ipca Laboratories Market Cap?
As of today, Ipca Laboratories market cap is 477.50B INR.
What Is Ipca Laboratories's Earnings Per Share (TTM)?
The Ipca Laboratories EPS (TTM) is 51.63.
When Is the Next Ipca Laboratories Earnings Date?
Ipca Laboratories will release its next earnings report on Nov 09, 2026.
From a Technical Analysis Perspective, Is IPCA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ipca Laboratories Stock Split?
Ipca Laboratories has split 3 times.
How Many Employees Does Ipca Laboratories Have?
Ipca Laboratories has 17210 employees.
What is the current trading status of Ipca Laboratories (IPCA)?
As of Aug 19, 2026, Ipca Laboratories (IPCA) is trading at a price of 1,882.10 INR, with a previous close of 1,882.10 INR. The stock has fluctuated within a day range of 1,862.30 INR to 1,919.00 INR, while its 52-week range spans from 1,251.60 INR to 1,945.10 INR.
What Is Ipca Laboratories (IPCA) Price Target According to Analysts?
The average 12-month price target for Ipca Laboratories is 1,928.67 INR, with a high estimate of 2118 INR and a low estimate of 1731 INR. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +2.47% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.